How to buy Innospec stock | $87.12

Innospec Inc is a specialty chemicals business based in the US. Innospec shares (IOSP) are listed on the NASDAQ and all prices are listed in US Dollars. Innospec employs 2,000 staff and has a trailing 12-month revenue of around USD$1.4 billion.

How to buy shares in Innospec

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Innospec. Find the stock by name or ticker symbol: IOSP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Innospec reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$87.12, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Innospec, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Innospec. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Innospec share price

Use our graph to track the performance of IOSP stocks over time.

Innospec shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$87.12
52-week range	USD$56.71 - USD$107.845
50-day moving average	USD$67.5743
200-day moving average	USD$73.1554
Wall St. target price	USD$90
PE ratio	28.9
Dividend yield	USD$1.04 (1.54%)
Earnings per share (TTM)	USD$2.212

Buy Innospec shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Innospec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Innospec Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Innospec price performance over time

Historical closes compared with the close of $87.12 from 2020-12-04

1 week (2020-11-25)	-0.39%
1 month (2020-11-04)	24.46%
3 months (2020-09-04)	17.67%
6 months (2020-06-04)	6.97%

1 year (2019-12-04)	-11.57%
2 years (2018-12-04)	26.94%
3 years (2017-12-04)	21.34%
5 years (2015-12-04)	51.75%

Is Innospec under- or over-valued?

Valuing Innospec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Innospec's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Innospec's P/E ratio

Innospec's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Innospec shares trade at around 29x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Innospec's EBITDA

Innospec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$168.2 million.

The EBITDA is a measure of a Innospec's overall financial performance and is widely used to measure a its profitability.

Innospec financials

Revenue TTM	USD$1.4 billion
Operating margin TTM	8.78%
Gross profit TTM	USD$470.6 million
Return on assets TTM	5.36%
Return on equity TTM	6.2%
Profit margin	3.96%
Book value	$36.6
Market capitalisation	USD$1.7 billion

TTM: trailing 12 months

Shorting Innospec shares

There are currently 262,057 Innospec shares held short by investors – that's known as Innospec's "short interest". This figure is 4.5% down from 274,336 last month.

There are a few different ways that this level of interest in shorting Innospec shares can be evaluated.

Innospec's "short interest ratio" (SIR)

Innospec's "short interest ratio" (SIR) is the quantity of Innospec shares currently shorted divided by the average quantity of Innospec shares traded daily (recently around 135080.92783505). Innospec's SIR currently stands at 1.94. In other words for every 100,000 Innospec shares traded daily on the market, roughly 1940 shares are currently held short.

However Innospec's short interest can also be evaluated against the total number of Innospec shares, or, against the total number of tradable Innospec shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Innospec's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Innospec shares in existence, roughly 10 shares are currently held short) or 0.0175% of the tradable shares (for every 100,000 tradable Innospec shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Innospec.

Find out more about how you can short Innospec stock.

Innospec share dividends

Dividend payout ratio: 25.3% of net profits

Recently Innospec has paid out, on average, around 25.3% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Innospec shareholders could enjoy a 1.54% return on their shares, in the form of dividend payments. In Innospec's case, that would currently equate to about $1.04 per share.

While Innospec's payout ratio might seem fairly standard, it's worth remembering that Innospec may be investing much of the rest of its net profits in future growth.

Innospec's most recent dividend payout was on 26 May 2020. The latest dividend was paid out to all shareholders who bought their shares by 15 May 2020 (the "ex-dividend date").

Have Innospec's shares ever split?

Innospec's shares were split on a 2:1 basis on 23 July 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Innospec shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Innospec shares which in turn could have impacted Innospec's share price.

Innospec share price volatility

Over the last 12 months, Innospec's shares have ranged in value from as little as $56.71 up to $107.845. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Innospec's is 1.3172. This would suggest that Innospec's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Innospec overview

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in environmental remediation business that manages the cleanup of redundant TEL facilities. The company sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction preparations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

Frequently asked questions

• What percentage of Innospec is owned by insiders or institutions?

  Currently 1.357% of Innospec shares are held by insiders and 95.677% by institutions.

• How many people work for Innospec?

  Latest data suggests 2,000 work at Innospec.

• When does the fiscal year end for Innospec?

  Innospec's fiscal year ends in December.

• Where is Innospec based?

  Innospec's address is: 8310 South Valley Highway, Englewood, CO, United States, 80112

• What is Innospec's ISIN number?

  Innospec's international securities identification number is: US45768S1050

• What is Innospec's CUSIP number?

  Innospec's Committee on Uniform Securities Identification Procedures number is: 45768S105